Tabrecta

Made by

• Novartis

Active Ingredient

Capmatinib hydrochloride hydrate

Prospectus

Approval date

2020/6/29

Treats

• Non-small cell lung cancer

Dosages

• TABRECTA tablets - 5055.5円／錠

• TABRECTA tablets - 6573.5円／錠